Primary information |
---|
sequence ID | Seq_1380 |
Peptide sequence | DLEPTVIDEIR |
CancerPDF_ID | CancerPDF_ID871, CancerPDF_ID9884, |
PMID | 19795908,21533267 |
Protein Name | Tubulin alpha-4A chain,Tubulin alpha-4A chain |
UniprotKB Entry Name | TBA4A_HUMAN,TBA4A_HUMAN |
Fluid | Plasma,Serum |
M/Z | 650.34,650.35 |
Charge | 2,2 |
Mass (in Da) | NA,NA |
fdr | NA,NA |
Profiling Technique | LC-MS,LC-MS |
Peptide Identification technique | MALDI-TOF/TOF,LC/MS/MS |
Quantification Technique | LC-MRM (multiple reaction monitoring),Multiple Reaction Monitoring |
Labelled/Label Free | Labelled,Label Free |
FDR | less than 7%,1.49 |
CancerPDF_ID | CancerPDF_ID871, CancerPDF_ID9884, |
p-Value | NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT |
Length | 11,11 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Lung adenocarcinoma |
Database | NCBI refseq Protein Database,Swissprot Database (57.4) |
Modification | NA,NA |
Number of Patients | "37 normal, 12 patients",62 lung adenocarcinoma and 30 healthy control |
Regulation | NA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" |
Validation | NA,MRM-based validation of 19 candidates |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |